Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds

被引：25

作者：

Dhar, T. G. Murali ^{[1
]}

Wrobleski, Stephen T. ^{[1
]}

Lin, Shuqun ^{[1
]}

Furch, Joseph A. ^{[1
]}

Nirschl, David S. ^{[1
]}

Fan, Yi ^{[1
]}

Todderud, Gordon ^{[1
]}

Pitt, Sidney ^{[1
]}

Doweyko, Arthur M. ^{[1
]}

Sack, John S. ^{[1
]}

Mathur, Arvind ^{[1
]}

McKinnon, Murray ^{[1
]}

Barrish, Joel C. ^{[1
]}

Dodd, John H. ^{[1
]}

Schieven, Gary L. ^{[1
]}

Leftheris, Katerina ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 18期

关键词：

p38; alpha; MAP kinase inhibitors; TNF alpha; X-ray co-crystallography;

D O I：

10.1016/j.bmcl.2007.07.029

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and structure-activity relationships (SAR) of p38 alpha MAP kinase inhibitors based on heterobicyclic scaffolds are described. This effort led to the identification of compound (21) as a potent inhibitor of p38a MAP kinase with good cellular potency toward the inhibition of TNF-alpha production. X-ray co-crystallography of an oxalamide analog (24) bound to unphosphorylated p38 alpha is also disclosed. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：5019 / 5024

页数：6

共 17 条

[1]

Adams JL, 2001, PROGR MED CHEM, V38, P1, DOI 10.1016/S0079-6468(08)70091-2

[2] Infliximab and ulcerative colitis [J].

Cottone, M ;

Mocciaro, F ;

Modesto, I .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (04) :401-408

[3] The discovery of novel chemotypes of p38 kinase inhibitors [J].

Diller, DJ ;

Lin, TH ;

Metzger, A .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) :953-965

[4]

Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421

[5]

DUGAR S, 2005, 7 WORLD C INFL MELB

[6]

DYCKMAN A, 2003, CHEM ABSTR, V139, DOI UNSP 292275

[7]

Fleischmann Roy, 2006, Expert Rev Clin Immunol, V2, P331, DOI 10.1586/1744666X.2.3.331

[8] Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development [J].

Goldstein, DM ;

Gabriel, T .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) :1017-1029

[9]

Grunke Mathias, 2005, Expert Rev Clin Immunol, V1, P313, DOI 10.1586/1744666X.1.3.313

[10] Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005 [J].

Hynes, J ;

Leftheris, K .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) :967-985

← 1 2 →